Johnson & Johnson

Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a broad range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas: immunology (e.g., rheumatoid arthritis, inflammatory bowel disease and psoriasis), infectious diseases and vaccines (e.g., HIV, hepatitis, respiratory infections and tuberculosis), neuroscience (e.g., Alzheimer's disease, mood disorders, and schizophrenia), oncology (e.g., prostate cancer, hematologic malignancies, and lung cancer), and cardiovascular and metabolic diseases (e.g., thrombosis and diabetes). The Medical Devices segment includes a broad range of products used in the orthopaedic, surgery, cardiovascular, diabetes care and vision care fields.

Company Growth (employees)
Type
Public
HQ
New Brunswick, US
Founded
1886
Size (employees)
126,400 (est)
Website
jnj.com
Johnson & Johnson was founded in 1886 and is headquartered in New Brunswick, US

Key People at Johnson & Johnson

Alex Gorsky

Alex Gorsky

CEO
Dominic J. Caruso

Dominic J. Caruso

CFO
Ronald A. Williams

Ronald A. Williams

Independent Director
Michael Sneed

Michael Sneed

VP, Global Corporate Affairs
Peter Fasolo

Peter Fasolo

Executive VP, CHRO
Paul Stoffels

Paul Stoffels

Executive VP & CSO

Johnson & Johnson Office Locations

Johnson & Johnson has an office in New Brunswick
New Brunswick, US (HQ)
One Johnson & Johnson Plaza

Johnson & Johnson Data and Metrics

Johnson & Johnson Financial Metrics

Johnson & Johnson's revenue was reported to be $71.9 b in FY, 2016 which is a 3% increase from the previous period.
USD

Revenue (FY, 2016)

71.9 b

Revenue growth (FY, 2015 - FY, 2016), %

3%

Gross profit (FY, 2016)

50.2 b

Gross profit margin (FY, 2016), %

70%

Net income (FY, 2016)

16.5 b

EBIT (FY, 2016)

16.5 b

Market capitalization (19-Sep-2017)

370.7 b

Cash (31-Dec-2016)

19 b

EV

374.2 b
Johnson & Johnson's current market capitalization is $370.7 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

71.3 b74.3 b70.1 b71.9 b

Revenue growth, %

4%(6%)3%

Cost of goods sold

22.3 b22.7 b21.5 b21.7 b

Gross profit

49 b51.6 b48.5 b50.2 b
USDY, 2010Y, 2011Y, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

15.8 b19.4 b24.5 b20.9 b14.5 b13.7 b19 b

Inventories

7.9 b8.2 b8.1 b8.1 b

Current Assets

56.4 b59.3 b60.2 b65 b

PP&E

16.7 b16.1 b15.9 b15.9 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

13.8 b16.3 b15.4 b16.5 b

Accounts Receivable

(632 m)(247 m)(433 m)(1.1 b)

Inventories

(622 m)(1.1 b)(449 m)(249 m)

Accounts Payable

1.8 b955 m656 m
USDY, 2016

EV/EBIT

22.6 x

EV/CFO

19.9 x

Revenue/Employee

566.7 k

Debt/Equity

0.3 x

Debt/Assets

0.2 x

Financial Leverage

2 x
Show all financial metrics

Johnson & Johnson Operating Metrics

FY, 2014FY, 2015FY, 2016

Discovery Projects

100150

Facilities

121119

Drugs Approved by FDA

2
Show all operating metrics

Johnson & Johnson Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Actelion PharmaceuticalsJanuary 26, 2017$30 b
Abott Medical OpticsSeptember 16, 2016$4.3 b
Vogue InternationalJune 02, 2016$3.3 b
Novira TherapeuticsNovember 08, 2015
XO1March 20, 2015
Alios BioPharmaSeptember 30, 2014$1.8 b
Aragon PharmaceuticalsJune 17, 2013$1 b

Johnson & Johnson Market Value History

Johnson & Johnson Revenue Breakdown

Johnson & Johnson Median Salaries

Source: 32 public H-1B filings from Johnson & Johnson

Traffic Overview of Johnson & Johnson

Johnson & Johnson Online and Social Media Presence

Johnson & Johnson Company Life and Culture

You may also be interested in